Dr Nick Scott presented at the NDARC Webinar Series on Thursday 12 May 2022.

This webinar presented modelled estimates of the health and economic benefits of achieving hepatitis C elimination in Australia. In order to achieve elimination and realize these benefits, uptake of testing and treatment must be high among people who inject drugs. The webinar also examined a recent modelling study on the impact and cost-effectiveness of incentives to facilitate testing and treatment uptake among people who inject drugs.


About the speaker

Dr Nick Scott, BSc (hons), PhD (Mathematics) is the Head of Modelling & Biostatistics at the Burnet Institute, an Adjunct Senior Research Fellow at Monash University, and an NHMRC Emerging Leader Fellow. He leads a team of modellers who work across a number of infectious diseases and public health problems, particularly those impacting vulnerable populations.

Date Commenced
13 May 2022
Resource Type
NDARC Seminars